Growth and growth hormone therapy in chi
โ
Stamoyannou, L.; Karachaliou, F.; Neou, P.; Papataxiarchou, K.; Pistevos, G.; Ba
๐
Article
๐
1997
๐
John Wiley and Sons
๐
English
โ 35 KB
๐ 3 views
The efficacy and safety of recombinant human growth hormone (hGH) administration was studied in children with achondroplasia. Fifteen children with achondroplasia, seven boys (4.8-12.2 years of age) and 12 girls (5.7-2.2 years of age), were treated daily with hGH at a dosage of 1 IU/kg/week. Auxolog